Novel saltwater treatment device


Cambridge Consultants develops innovative nebuliser to treat cystic fibrosis Observing surfers with cystic fibrosis (CF) led scientists to discover that the inhaled mist of seawater has a therapeutic effect on the lung problems associated with the disease. Now the findings have been used by pharmaceutical company Parion Sciences and product development firm Cambridge Consultants in …




Continue reading